Back to Sanders Capital, LLC Sanders Capital, LLC

ABBVABBV

Showing 9 of 32 quarters

Position history for Sanders Capital, LLCSanders Capital, LLC's holdings in AbbVie Inc.

Yes. Sanders Capital holds 462,723 shares of ABBV (AbbVie), worth $121M, as of its Q3 2026 13F filing. It reduced the position by 21,240 shares (-4.4%) from Q2 2026. Sanders Capital has held ABBV in every 13F on record since Q4 2018, 32 quarterly filings. ABBV is 0.1% of Sanders Capital's reported 13F portfolio.

Current Value

$121M

Current Shares

462,723

Total Value Change

+$11.7M

Total Shares Change

-90,730

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
462,723
-4.4%
$121M0.1%$259.99
0
2026-Q2
Decreased
483,963
-6.3%
$121.8M0.1%$248.34
0
2026-Q1
Decreased
516,593
-2.9%
$112.4M0.1%$212.87
0
2025-Q4
Decreased
532,163
-3.0%
$121.6M0.1%$221.85
0
2025-Q3
Decreased
548,323
-0.1%
$127M0.2%$223.20
0
2025-Q2
Increased
549,143
+0.1%
$101.9M0.1%$177.40
37
2025-Q1
Decreased
548,763
-0.7%
$115M0.2%$198.41
0
2024-Q4
Decreased
552,523
-0.2%
$98.2M0.1%$166.71
0
2024-Q3
Decreased
553,453
-0.3%
$109.3M0.2%$183.80
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used